This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Novaliq Gmbh. Active years: 2023-2026.
Company Filing History:
Years Active: 2023-2026
Title: Diana Strehl: Innovator in Pharmaceutical Compositions
Introduction
Diana Strehl is a prominent inventor based in Heidelberg, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for the treatment of glaucoma and related conditions. With a total of 3 patents to her name, her work has the potential to impact the lives of many patients.
Latest Patents
One of her latest patents is focused on pharmaceutical compositions comprising timolol. This invention relates to a composition that includes the beta 1 (β)-receptor blocker timolol and a liquid vehicle made of a semifluorinated alkane. The composition is designed for topical administration, particularly for ophthalmic use, and aims to treat glaucoma, increased intraocular pressure, ocular hypertension, and associated symptoms. Another notable patent involves ophthalmic compositions that include tafluprost for the treatment of glaucoma. This invention provides a pharmaceutical composition intended for the prevention or therapy of glaucoma and related conditions, utilizing tafluprost and a semifluorinated alkane.
Career Highlights
Diana has worked with notable organizations such as Novaliq GmbH and Tel Aviv University. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to innovative research and development.
Collaborations
Diana has collaborated with professionals like Frank Löscher and Kirsten Eickhoff, enhancing her work through shared expertise and insights.
Conclusion
Diana Strehl's contributions to pharmaceutical innovations, particularly in glaucoma treatment, highlight her role as a significant inventor in the field. Her patents reflect a commitment to improving patient care through advanced pharmaceutical compositions.